However, no studies have confirmed a mortality benefit with growth hormone therapy, Dr. Molitch said.
“Some do suggest that mortality is increased in those with hypopituitarism, but it's never been proven that hypopituitarism is the cause of this, or that growth hormone decreases it,” he said.
Bone mineral density testing may facilitate decisions about whether to continue therapy. DR. MOLITCH